Skip to main content
. 2016 May 30;8:67–76. doi: 10.2147/CMAR.S102383

Table 6.

Adverse events among patients ever treated with MKIs (n=206) and chemotherapies (n=127)

Adverse events Chemo
(n=127) (%)
MKI
(n=206) (%)
Any adverse event 22.0 19.9
Nausea and vomiting 12.6 1.0
Loss of appetite 9.4 7.3
Hair loss 8.7 1.5
Diarrhea 7.9 11.2
Fatigue 7.1 8.3
Mouth sores 7.1 6.8
Neuropathy 5.5 2.4
Hematologic toxicity 4.7 0.5
Hand-foot syndrome 4.7 8.7
Weight loss 4.7 1.9
Dysphonia 2.4 1.0
Infections 2.4 0.5
Hypertension 1.6 5.8

Abbreviation: MKI, multikinase inhibitor.